FIQIX
Price
$40.80
Change
-$0.15 (-0.37%)
Updated
Jun 2 closing price
Net Assets
5.61B
MCISX
Price
$21.58
Change
-$0.15 (-0.69%)
Updated
Jun 2 closing price
Net Assets
4.78B
Interact to see
Advertisement

FIQIX vs MCISX

Header iconFIQIX vs MCISX Comparison
Open Charts FIQIX vs MCISXBanner chart's image
FIQIX vs MCISX Comparison Chart in %
View a ticker or compare two or three
VS
FIQIX vs. MCISX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIQIX is a Hold and MCISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FIQIX has more cash in the bank: 5.61B vs. MCISX (4.78B). FIQIX pays higher dividends than MCISX: FIQIX (3.11) vs MCISX (0.89). FIQIX was incepted earlier than MCISX: FIQIX (8 years) vs MCISX (19 years). MCISX (3.49) is less costly to investors than FIQIX (0.83). MCISX is a more actively managed with annual turnover of: 49.00 vs. FIQIX (24.00). FIQIX has a lower initial minimum investment than MCISX: FIQIX (0) vs MCISX (2500). MCISX annual gain was more profitable for investors over the last year : 26.73 vs. FIQIX (18.81). FIQIX return over 5 years is better than : 30.29 vs. MCISX (26.42).
FIQIXMCISXFIQIX / MCISX
Total Expense Ratio0.832.1040%
Annual Report Gross Expense Ratio0.833.4924%
Fund Existence8 years19 years-
Gain YTD10.64613.47379%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B4.78B117%
Annual Yield % from dividends3.110.89350%
Returns for 1 year18.8126.7370%
Returns for 3 years50.5168.2074%
Returns for 5 years30.2926.42115%
Returns for 10 yearsN/A106.33-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MENS2.160.10
+4.85%
Jyong Biotech Ltd
MWA25.080.41
+1.66%
Mueller Water Products
CPNG16.730.11
+0.66%
Coupang
WLKP23.270.09
+0.39%
Westlake Chemical Partners LP
ERNA8.07-1.04
-11.46%
Ernexa Therapeutics Inc.